In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6
1999

Steroid Enzymes in Breast Tumors and Their Link to Interleukin-6

Sample size: 73 publication Evidence: moderate

Author Information

Author(s): Speirs V, Walton D S, Hall M-C, Atkin S L

Primary Institution: University of Hull

Hypothesis

The study investigates the expression of steroid-converting enzymes in human breast tumors and their association with interleukin-6.

Conclusion

The study suggests that steroid-converting enzymes and interleukin-6 may work together to promote breast cancer growth.

Supporting Evidence

  • All but one tumor expressed at least one isoform of 17-HSD.
  • Nine tumors expressed 17-HSD isoforms I–IV.
  • The most common combination of isoforms was 17-HSD II, III, and IV.
  • Seventeen tumors expressed two isoforms of 17-HSD, with II and IV being predominant.
  • In primary epithelial cultures, HSD I was the most expressed enzyme at 86%.

Takeaway

This study looked at how certain enzymes in breast tumors help make hormones that can make cancer grow, especially when linked to a specific protein called interleukin-6.

Methodology

The study used reverse transcription polymerase chain reaction to analyze enzyme expression in breast tumor biopsies and primary cell cultures.

Participant Demographics

The study included human breast tumor biopsies and primary cultures from patients, some of whom had a family history of breast cancer.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690749

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication